Sec Form 4 Filing - Turitz Andrew @ Teladoc Health, Inc. - 2022-03-02

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Turitz Andrew 2. Issuer Name and Ticker or Trading Symbol Teladoc Health, Inc. [ TDOC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) SVP - BUSINESS DEVELOPMENT (Last) (First) (Middle) C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 3. Date of Earliest Transaction (MM/DD/YY) 03/02/2022 (Street) PURCHASE, NY10577 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/02/2022 M 1,205 A 8,761 D Common Stock 03/02/2022 M 2,050 A 10,811 D Common Stock 03/02/2022 M 515 A 11,326 D Common Stock 03/02/2022 M 1,147 A 12,473 D Common Stock 03/02/2022 M 868 A 13,341 D Common Stock 03/03/2022 S 1,754( 3 ) D $ 70.239 11,587 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acqui red (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units ( 1 ) 03/02/2022 M 1,205 ( 4 ) ( 4 ) Common Stock 1,205 $ 0 1,205 D Performance Stock Units ( 2 ) 03/02/2022 M 2,050 ( 5 ) ( 5 ) Common Stock 2,050 $ 0 2,048 D Performance Stock Units ( 6 ) 03/02/2022 A 1,030( 7 ) ( 8 ) ( 8 ) Common Stock 1,030 $ 0 1,030 D Performance Stock Units ( 2 ) 03/02/2022 M 515 ( 9 ) ( 9 ) Common Stock 515 $ 0 515 D Restricted Stock Units ( 1 ) 03/02/2022 M 1,147 ( 10 ) ( 10 ) Common Stock 1,147 $ 0 2,295 D Performance Stock Units ( 6 ) 03/02/2022 A 2,602( 11 ) ( 12 ) ( 12 ) Common Stock 2,602 $ 0 2,602 D Performance Stock Units ( 2 ) 03/02/2022 M 868 ( 13 ) ( 13 ) Common Stock 868 $ 0 1,734 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Turitz Andrew C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE, NY10577 SVP - BUSINESS DEVELOPMENT Signatures /s/ Adam C. Vandervoort, Attorney-in-Fact 03/04/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. ( 2 )Performance stock units convert to shares of TDOC common stock on a one-for-one basis. ( 3 )Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. ( 4 )On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. ( 5 )On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. ( 6 )Each performance stock unit represents a contingent right to receive one share of TDOC common stock. ( 7 )Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021. ( 8 )The performance stock units vest in two substantially eq ual annual installments beginning on March 2, 2022. ( 9 )On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. ( 10 )On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. ( 11 )Performance award amount determined based on metrics in respect of the issuer's 2021 financial results ( 12 )The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. ( 13 )On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.